Increasing Resiliency Among Early Post-Treatment Lymphoma Survivors

Recruiting now · Not applicable

Conditions studied: Lymphoma

In brief

The goal of this clinical trial is to learn if a mind body resilience group program can help increase lymphoma survivors' ability to cope with and manage the challenges that come with the transition into early post treatment survivorship.

Key facts

Study ID

NCT07014293

Run by

Massachusetts General Hospital

People needed

254

Starts

2026-07-01

Expected to finish

2030-07-01

Last updated by the study team

2026-07-09

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• English speaking adult (18 years or older at enrollment)
• At least 6-months post-lymphoma diagnosis and within 2 years of completing active, curative treatment for lymphoma (includes surgery, chemotherapy/immunotherapy/radiation therapy, or other)

You may not qualify if…

• Active Psychiatric or cognitive comorbidity as determined by site PI or treating clinician
• Unwilling or unable to participate using telehealth platform

Where it is running

• Mass General Brigham — Boston, Massachusetts, United States (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.